Nineteen games now benefit from Intel's Binary Optimization Tool (iBOT), but the new additions are a real mix of new and old ...

Researchers have analyzed a high-severity vulnerability in Linux that’s able to escalate untrusted users to root by ...

If you're on a mission to improve your health and wellness, and Linux is your OS of choice, there are plenty of apps to help ...

Microsoft lists the change in update KB5089573 as a "General Performance" improvement, saying it accelerates app launches and core shell experiences such as the Start menu, ...

Dublin, Feb. 06, 2026 (GLOBE NEWSWIRE) -- The "Cannabis Use Disorder Market - A Global and Regional Analysis: Focus on Country and Regional Analysis, 2025-2035" report has been added to ...

The strategy of taking aim at IL-4Ra (type I and II receptors) and IL-31 by way of a bispecific antibody in atopic dermatitis (AD) has not worked out as well as Johnson & Johnson (J&J) hoped when, ...

With approximately $9.5 million in cash reserves and no debt, the Company is ready to leverage strengthened vertical integration as clinical-grade psilocybin moves into Phase IIb trials NEW YORK, Dec.

NEW YORK - Psyence Biomedical Ltd. (NASDAQ:PBM) announced Friday that its PsyLabs™ psilocybin product has received approval from the Bellberry Human Research Ethics Committee for use in an ongoing ...

With approximately $9.5 million in cash reserves and no debt, the Company is ready to leverage strengthened vertical integration as clinical-grade psilocybin moves into Phase IIb trials This approval ...

NEW YORK, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine ...